diphenyleneiodonium has been researched along with simvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, W; Liu, H; Liu, S; Shang, F; Wang, J; Xu, Z; Zhang, L; Zhao, L; Zheng, Q | 1 |
| Chen, Y; Li, Z; Liu, T; Meng, R; Peng, G; Wu, G; Yu, J; Zhang, S; Zhao, Y | 1 |
2 other study(ies) available for diphenyleneiodonium and simvastatin
| Article | Year |
|---|---|
Simvastatin inhibits lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiomyocytes: The role of reactive oxygen species.
Topics: Acetylcysteine; Animals; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Hydrogen Peroxide; Hypolipidemic Agents; Lipopolysaccharides; Mevalonic Acid; Myocytes, Cardiac; NADPH Oxidases; Onium Compounds; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Simvastatin; Tumor Necrosis Factor-alpha | 2006 |
Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization.
Topics: Angiogenesis Modulating Agents; Animals; Antineoplastic Agents; Capillary Permeability; Carcinoma, Lewis Lung; Cell Hypoxia; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Synergism; Female; Free Radical Scavengers; Human Umbilical Vein Endothelial Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microvessels; Nitric Oxide Synthase Type III; Onium Compounds; Reactive Oxygen Species; Regional Blood Flow; Simvastatin; Tumor Burden; Ultrasonography; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |